Because consumers can potentially pay more for their medications with insurance coverage than if they lacked coverage altogether, additional steps…
According to a new op-ed in the Wall Street Journal, many health plans deny coverage for medical treatments and impose…
A recent survey by the Doctor-Patient Rights Project found that nearly 53 million insured Americans are denied coverage for treatments…
The FDA’s Risk Evaluation and Mitigation Strategies (REMS) program ensures valuable medicines that would not otherwise be on the market…
Newsweek published an op-ed by Aimed Alliance’s Executive Director, Stacey L. Worthy in which she discusses how insurance companies interfere…
In a new op-ed, Dr. Tom Coburn points out that while the average out-of-pocket costs for patient are falling, an…
On Monday, a class-action lawsuit was filed against CVS Health, alleging that the company colluded with third-party pharmacy benefit managers…
Creating a transparent database of emergency care costs and reimbursement rates can protect patients from surprise medical billing after an…
Precision medicine is crucial to providing highly effective, high-value care to patients with serious diseases. Celgene CEO, Mark Alles, states…
Yesterday, the Senate passed a bill requiring the pharmaceutical industry to study the safety and efficacy of adult cancer treatments…